Evolution in the ophthalmic space is rapidly changing in both diagnosis and treatment of common eye conditions. Clinical trials serve as a frame for physicians to learn about and practice evidence-based medicine. Specifically, in regard to anterior segment surgical care the innovation is blazing. The purpose of this lecture is to highlight the future of ophthalmic surgery and review a few of the technologies or treatments that are on the horizon by leveraging the speakers' experiences in clinical trials. The speakers will discuss some recently approved technologies as well as some that are in the final stages of clinical trials. Exciting technology discussions will revolve around intraocular lenses (IOLs), post-operative drug delivery, corneal surgeries, glaucoma drug delivery, and many more. The aim of the course will be to give a glimpse into the future for eyecare and what it means for our future.

Course Code:



Mitch Ibach, O.D.

Michael Greenwood, M.D.



AOA Expiration Date:


Related News

How the HIPAA Privacy Rule applies in a public health emergency

In response to Hurricane Ian, the federal government takes steps to ease the pains of disaster recovery in Florida. Learn more about the federal waivers—and how you can help colleagues affected by disaster.

AOA+ aims for new heights: 3,000 in DC for ’23

Learn more about AOA+ travel grant opportunities to attend this one-of-a-kind experience for optometry students, newly graduated doctors, and educators in Washington, D.C., June 21-24, 2023.

Partners in care

The AOA has created a trove of practice management tools and services that can power practices forward in a profession and health care landscape that increasingly demands doctors practice at their highest levels and creates greater opportunities to develop and empower paraoptometric staff. These days, change is out of necessity.